Literature DB >> 17437613

High prevalence of restless legs syndrome in multiple sclerosis.

M Manconi1, M Fabbrini, E Bonanni, M Filippi, M Rocca, L Murri, L Ferini-Strambi.   

Abstract

Despite the fact that multiple sclerosis (MS) patients often include leg restlessness as a sensory symptom, MS is not mentioned amongst symptomatic restless legs syndrome (RLS) forms. The aim of this study was to estimate RLS prevalence in a large population of MS patients, comparing clinical and MRI findings between patients with and without RLS. Each of the 156 MS patients (100 females, 56 males, mean age 40.7 +/- 10.4) enrolled in a prospective study underwent a medical history interview, a neurological examination with the assessment of the Expanded Disability Status Scale (EDSS), and a structured questionnaire to verify the presence and features of RLS. Conventional brain-spinal MRIs of 99 subjects were also evaluated and compared between patients with and without RLS. Fifty-one subjects (32.7%) (mean age 43.8 +/- 12.8) met the criteria for RLS. In a few patients (8.5%), the RLS preceded clinical MS onset, whilst in the remaining cases the RLS was followed by or was simultaneous with clinical MS onset. Comparing the RLS group with the group without RLS, no significant differences were found in MS duration, gender, and referred sleep habits. The primary progressive MS course was more represented in the RLS group, which also showed a higher EDSS score. RLS is a very common finding in MS patients and should be considered amongst the symptomatic RLS forms. RLS is also associated with higher disability.

Entities:  

Mesh:

Year:  2007        PMID: 17437613     DOI: 10.1111/j.1468-1331.2007.01740.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  30 in total

Review 1.  Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.

Authors:  Tiffany J Braley; Ronald D Chervin
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

Review 2.  An update on the pathophysiology and genetics of restless legs syndrome.

Authors:  Lynn Marie Trotti; Srinivas Bhadriraju; David B Rye
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

3.  Restless leg syndrome and multiple sclerosis: a case-control study in China.

Authors:  Gangqiong Liu; Xiao Feng; Chao Lan; Ziqiang Zhu; Shengli Ma; Yu Guo; Rui Xue
Journal:  Sleep Breath       Date:  2015-05-24       Impact factor: 2.816

4.  Genome-wide association study of severity in multiple sclerosis.

Authors: 
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

5.  Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome.

Authors:  James R Connor; Padmavathi Ponnuru; Byeong-Yeul Lee; Gerald D Podskalny; Shoaib Alam; Richard P Allen; Christopher J Earley; Qing X Yang
Journal:  Sleep Med       Date:  2011-05-12       Impact factor: 3.492

6.  Comparison of Sleep Problems in Individuals with Spinal Cord Injury and Multiple Sclerosis.

Authors:  Donald J Fogelberg; Abbey J Hughes; Michael V Vitiello; Jeanne M Hoffman; Dagmar Amtmann
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

7.  Sleep disorders in patients with multiple sclerosis.

Authors:  Zuzana Čarnická; Branislav Kollár; Pavel Šiarnik; Lucia Krížová; Katarína Klobučníková; Peter Turčáni
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

Review 8.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

Review 9.  Economic and human costs of restless legs syndrome.

Authors:  Thomas Reinhold; Falk Müller-Riemenschneider; Stefan N Willich; Bernd Brüggenjürgen
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Restless legs syndrome in a primary contact setting: a case report.

Authors:  Maja Stupar
Journal:  J Can Chiropr Assoc       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.